- Home
- BCAX vs OMI Comparison
BCAX vs OMI Comparison
Compare BCAX & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- OMI
- Stock Information
- Founded
- BCAX 2018
- OMI 1882
- Country
- BCAX United States
- OMI United States
- Employees
- BCAX N/A
- OMI N/A
- Industry
- BCAX
- OMI Medical Specialities
- Sector
- BCAX
- OMI Health Care
- Exchange
- BCAX NYSE
- OMI Nasdaq
- Market Cap
- BCAX 1.0B
- OMI 1.0B
- IPO Year
- BCAX 2024
- OMI N/A
- Fundamental
- Price
- BCAX $16.34
- OMI $12.72
- Analyst Decision
- BCAX Strong Buy
- OMI Buy
- Analyst Count
- BCAX 5
- OMI 6
- Target Price
- BCAX $41.33
- OMI $19.58
- AVG Volume (30 Days)
- BCAX 347.7K
- OMI 476.3K
- Earning Date
- BCAX 02-16-2025
- OMI 11-04-2024
- Dividend Yield
- BCAX N/A
- OMI N/A
- EPS Growth
- BCAX N/A
- OMI N/A
- EPS
- BCAX N/A
- OMI N/A
- Revenue
- BCAX N/A
- OMI $10,660,960,000.00
- Revenue This Year
- BCAX N/A
- OMI $4.90
- Revenue Next Year
- BCAX N/A
- OMI $3.63
- P/E Ratio
- BCAX N/A
- OMI N/A
- Revenue Growth
- BCAX N/A
- OMI 4.22
- 52 Week Low
- BCAX $16.29
- OMI $11.42
- 52 Week High
- BCAX $28.09
- OMI $28.35
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- OMI 46.50
- Support Level
- BCAX N/A
- OMI $12.84
- Resistance Level
- BCAX N/A
- OMI $14.46
- Average True Range (ATR)
- BCAX 0.00
- OMI 0.58
- MACD
- BCAX 0.00
- OMI -0.06
- Stochastic Oscillator
- BCAX 0.00
- OMI 20.59
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.